Hartmann + Glucose, Viaflo Baxter

Hartmann + Glucose, Viaflo Baxter is an intravenous solution that contains potassium chloride, sodium chloride, calcium chloride dihydrate, glucose, and sodium lactate in standard concentrations. It is supplied as a sterile, ready‑to‑use bag for infusion. The product is marketed in the European Union and is prescribed for fluid and electrolyte replacement in clinical settings. It is indicated for patients requiring rapid volume expansion, postoperative hydration, or maintenance of metabolic balance.

Hartmann + Glucose is used in a variety of clinical situations where fluid, electrolyte, and energy replacement are needed.

- Fluid replacement in hypovolemia or shock. - Electrolyte replenishment during dehydration or electrolyte loss. - Post‑operative hydration to support recovery after surgery. - Intra‑operative volume expansion during major surgical procedures. - Maintenance therapy for patients receiving parenteral nutrition. - Support for patients with metabolic acidosis when combined with appropriate therapy.

Adverse reactions to Hartmann + Glucose are generally infrequent, but they can be categorized by frequency and severity.

Common: - Mild infusion site irritation or erythema. - Transient hyperglycemia in patients with impaired glucose tolerance. - Slight electrolyte disturbances such as mild hypernatremia or hypokalemia. - Low‑grade fever or chills during rapid infusion. - Local phlebitis at the catheter site.

Serious: - Severe hyperkalemia leading to cardiac arrhythmia. - Fluid overload causing pulmonary edema. - Anaphylactic or severe allergic reaction to solution components. - Severe metabolic acidosis. - Life‑threatening cardiac arrhythmias due to electrolyte imbalance.

When prescribing or administering Hartmann + Glucose, clinicians should observe several precautionary measures to minimize risk.

- Assess baseline electrolyte levels and renal function before infusion. - Adjust infusion rate in patients at risk of fluid overload, such as heart failure or renal insufficiency. - Monitor blood glucose in diabetic or critically ill patients. - Avoid rapid large‑volume bolus unless clinically indicated. - Use aseptic technique to prevent contamination of the IV bag. - Consider compatibility with other IV medications before co‑administration. - Document any adverse reactions promptly.

Hartmann + Glucose may interact with other drugs or solutions; awareness of these interactions helps ensure safe use.

Avoid: - Concurrent administration of potassium‑sparing diuretics or ACE inhibitors in patients with impaired renal function (risk of hyperkalemia). - Co‑infusion with calcium‑containing solutions that are not compatible (risk of precipitation). - Use with high‑dose insulin without glucose monitoring (risk of hypoglycemia).

Use with caution: - Simultaneous IV antibiotics that may cause incompatibility (e.g., ceftriaxone). - Blood products that require separate lines to avoid mixing. - Medications that affect fluid balance such as mannitol or hypertonic saline. - Vasopressors that may alter hemodynamics during rapid infusion.